Beacon Biosignals made waves in the healthcare tech sector today with the announcement of FDA 510(k) clearance for a progressive machine learning software designed to change the analysis of sleep patterns.
American pharma major Eli Lilly sees India as its launchpad for a new growth trajectory, using its new drugs for diabetes and obesity as the fuel. Will this strategic pivot work? - Issue Date: Mar 31, 2024